Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Incyte licenses RNA amplification technology and related patent

March 27, 1998

FDA advisory committee recommends expanded labeling for CEPRATE SC System

March 26, 1998

Ribozyme, Parke-Davis collaboration confirmed

March 25, 1998

Progenitor, CAT establish gene-to-clinic collaboration

March 25, 1998

T7T7 increases efficacy of cancer gene therapy in preclinical studies

March 24, 1998

Progress made in Lilly/Emisphere protein delivery collaboration

March 20, 1998

LifeCell will be awarded U.S. patent for blood cell preservation technology

March 19, 1998

Morphogenesis awarded phase I SBIR grant

March 18, 1998

SangStat and Dyax enter license agreement

March 17, 1998

Cornerstone patent awarded to Hyal

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...